Nanomedicine strategies for heating “cold” ovarian cancer (OC): next evolution in immunotherapy of OC
Y Yang, T Zhao, Q Chen, Y Li, Z Xiao… - Advanced …, 2022 - Wiley Online Library
Immunotherapy has revolutionized cancer treatment, dramatically improving survival rates of
melanoma and lung cancer patients. Nevertheless, immunotherapy is almost ineffective …
melanoma and lung cancer patients. Nevertheless, immunotherapy is almost ineffective …
[HTML][HTML] Image-guided cancer surgery: a narrative review on imaging modalities and emerging nanotechnology strategies
B Bortot, A Mangogna, G Di Lorenzo, G Stabile… - Journal of …, 2023 - Springer
Surgical resection is the cornerstone of solid tumour treatment. Current techniques for
evaluating margin statuses, such as frozen section, imprint cytology, and intraoperative …
evaluating margin statuses, such as frozen section, imprint cytology, and intraoperative …
[HTML][HTML] Preparation, characterization, and Co-delivery of cisplatin and doxorubicin-loaded liposomes to enhance anticancer Activities
MB Parsa, F Tafvizi, V Chaleshi, M Ebadi - Heliyon, 2023 - cell.com
Ovarian cancer stands as a leading cause of cancer-related deaths among women globally.
This malignancy has hindered successful treatment attempts due to its inherent resistance to …
This malignancy has hindered successful treatment attempts due to its inherent resistance to …
[HTML][HTML] Advanced photodynamic therapy with an engineered M13 phage targeting EGFR: Mitochondrial localization and autophagy induction in ovarian cancer cell …
B Bortot, M Apollonio, G Baj, L Andolfi, L Zupin… - Free Radical Biology …, 2022 - Elsevier
Photodynamic therapy (PDT) is a potential synergistic approach to chemotherapy for treating
ovarian cancer, the most lethal gynecologic malignancy. Here we used M13 bacteriophage …
ovarian cancer, the most lethal gynecologic malignancy. Here we used M13 bacteriophage …
[HTML][HTML] The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation
H Wang, L Fang, J Jiang, Y Kuang, B Wang… - Cell death & …, 2018 - nature.com
As a component of p53-dependent lncRNA (long non-coding RNA), PANDAR (the promoter
of CDKN1A antisense DNA damage activated RNA) participates in the epigenetic regulation …
of CDKN1A antisense DNA damage activated RNA) participates in the epigenetic regulation …
Actively targeted nanocarriers for drug delivery to cancer cells
S Biffi, R Voltan, B Bortot, G Zauli… - Expert opinion on drug …, 2019 - Taylor & Francis
Introduction: Progressive breakthroughs in nanomedicine have been instrumental for the
clinical translation of actively targeted drug-delivery approaches. Besides storing large …
clinical translation of actively targeted drug-delivery approaches. Besides storing large …
[HTML][HTML] Characterization of antimicrobial, antioxidant, and leishmanicidal activities of Schiff base derivatives of 4-aminoantipyrine
R Teran, R Guevara, J Mora, L Dobronski… - Molecules, 2019 - mdpi.com
Our main interest is the characterization of compounds to support the development of
alternatives to currently marketed drugs that are losing effectiveness due to the development …
alternatives to currently marketed drugs that are losing effectiveness due to the development …
Revamping precision treatment with nanoparticles envisaging effective drug delivery systems for ovarian cancer
Ovarian cancer occurs through the proliferation of cells at gynaecological sites and is the
major cause of demise in women. One of the conventional treatments for ovarian cancer is …
major cause of demise in women. One of the conventional treatments for ovarian cancer is …
[HTML][HTML] Circular PVT1 regulates cell proliferation and invasion via miR-149-5p/FOXM1 axis in ovarian cancer
M Li, C Chi, L Zhou, Y Chen, X Tang - Journal of Cancer, 2021 - ncbi.nlm.nih.gov
Long non-coding RNA plasmacytoma variant translocation 1 (PVT1) is a dysregulated gene
in malignancy and is associated with oncogenesis. In this study, we found PVT1 RNA was …
in malignancy and is associated with oncogenesis. In this study, we found PVT1 RNA was …
[HTML][HTML] Photodynamic therapy using a new folate receptor-targeted photosensitizer on peritoneal ovarian cancer cells induces the release of extracellular vesicles …
M Baydoun, O Moralès, C Frochot, C Ludovic… - Journal of Clinical …, 2020 - mdpi.com
Often discovered at an advanced stage, ovarian cancer progresses to peritoneal carcinoma,
which corresponds to the invasion of the serosa by multiple tumor implants. The current …
which corresponds to the invasion of the serosa by multiple tumor implants. The current …